From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
Patient
t1/2 (hrs)
AP
10.5
HL
5.1
FC
9.1
NR
7.3
TD
5.0
mean value ± s.d.
4.4 ± 3.5